Abstract
Background
Chronic generalized myositis has not so far been reported as a complication of chronic active Epstein–Barr virus infection (CAEBV). We encountered three patients with chronic generalized myositis mimicking polymyositis associated with CAEBV.
Methods
To clarify the pathological character of this myositis, we investigated the distribution, clonality, and the immunophenotype of EBV–infected cells and lymphocytes infiltrating in muscles.
Results
Clinically, two patients showed symmetrical proximal weakness and muscle atrophy as the initial and main symptom. Although the condition resembled polymyositis, they had also lingual and/or orbital myositis. The other patient showed generalized myositis at the late phase of CAEBV. In all of them, immunotherapy was ineffective and prognosis was poor. Intramuscular infiltrating lymphocytes in our patients were mainly CD45RO+, CD3+, CD4–, CD8–, TCR βF1–, TCR δTCS1–, CD56–, CD79a–, CD21–, HLA-DR+, ZEBRA –, LMP1–, and EBER+ T cells. Oligoclonal expansion of EBV–infected T cells was shown in the muscles. However, there were no malignant lymphocytes.
Conclusions
This new form of myositis must be distinguished from polymyositis and the other conventional forms of myositis. Careful investigation of hidden CAEBV is recommended when patients present with steroid non–responsive chronic progressive generalized myositis, in particular, with lingual or orbital involvement.
Similar content being viewed by others
References
Arahata K, Engel A (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16:193–208
Hays AP, Ganboa ET (1994) Acute viral myositis. In: Engel A, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1399–1418
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407
Bohan A, Peter JB, Bowman RL, Pearson CM (1977) Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56:255–286
Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL (1987) The “chronic, active Epstein-Barr virus infection” syndrome and primary fibromyalgia. Arthritis Rheum 30:1132–1136
Buchwald D, Sullivan JL, Leddy S, Komaroff AL (1988) “Chronic Epstein- Barr virus infection” syndrome and polymyalgia rheumatica. J Rheumatol 15:479–482
Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 348:481–492
Cope AP (2003) Exploring the reciprocal relationship between immunity and inflammation in chronic inflammatory arthritis. Rheumatology 42:716–731
De Vere R, Bradley WG (1975) Polymyositis: its presentation, morbidity and mortality. Brain 98:637–666
Diss TC, Watts M, Pan LX, Burke M, Linch D, Isaacson PG (1995) The polymerase chain reaction in the demonstration of monoclonality in T cell lymphomas. J Clin Pathol 48:1045–1050
Englund P, Lindroos E, Nennesmo I, Klareskog L (2001) Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 159:1263–1273
Goudie RB, Karim SN, Mills K, Alcorn M, Lee FD (1990) A sensitive method of screening for dominant T cell clones by amplification of T cell gamma gene rearrangements with the polymerase chain reaction. J Pathol 162:191–196
Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF (1983) Aberrant expression of HLADR antigen on thyrocytes in Graves’ disease: Relevance for autoimmunity. Lancet 2:1111–1115
Hashimoto Y, Nawata Y, Kurasawa K, Takabayashi K, Oda K, Mikata A, Iwamoto I (1995) Investigation of EB virus and cytomegalovirus in rapidly progressive interstitial pneumonitis in polymyositis/dermatomyositis by in situ hybridization and polymerase chain reaction. Clin Immunol Immunopathol 77:298–306
Inukai A, Kuru S, Liang Y, Takano A, Kobayashi Y, Sakai M, Doyu M, Sobue G (2000) Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis. Muscle Nerve 23:385–392
Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K (1997) Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 54:276–281
Kawa K (2000) Epstein-Barr virus-associated disease in human. Int J Hematol 71:108–117
Kibler R, Lucas DO, Hicks MJ, Poulos BT, Jones JF (1985) Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol 5:46–54
Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T (1999) Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37:132–136
Maia DM, Peace-Brewer AL (2000) Chronic active Epstein-Barr virus infection. Curr Opin Hematol 7:59–63
Matthews WB, Burne JC (1953) The neurological aspects of dermatomyositis. J Neurol Neurosurg Psychiatry 16:49–55
Ohga S, Kimura N, Takada H, Nagano M, Ohshima K, Nomura A, Muraoka K, Take H, Yamamori S, Hara T (1999) Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease. Am J Hematol 61:26–33
Ohtsuka M, Iwatsuki K, Kaneko R, Akiba H, Kikuchi S, Harada H, Kaneko F (1999) Epstein-Barr virus-associated lymphoid hyperplasia of the eyelid characterized by intramuscular infiltration. Br J Dermatol 140:358–359
Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K (2000) Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet 356:223–224
Okano M (1998) Epstein-Barr virus infection and its role in the expanding spectrum of human diseases. Acta Pediatr 87:11–18
Person CM (1963) Pattern of polymyositis and their response to treatment. Ann Intern Med 59:827–838
Pignone A, Fiori G, Del Rosso A, Generini S, Matucci-Cerinic M (2002) The pathogenesis of inflammatory muscle disease: On the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis. Autoimmun Rev 1:226–232
Sugiyama K, Ito M, Ichimi R, Higashikawa M, Kawasaki H, Komada Y, Sakurai M, Wakiguchi H, Kikuta H, Fukayama M (1997) A case of Epstein- Barr virus infection with exophthalmos and ocular muscle swelling. Acta Pediatr Japonica 39:694–697
Targoff IN, Miller FW, Medsger TA Jr, Oddis CV (1997) Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 9:527–535
Traub NR, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889
Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H (2001) Impaired cytotoxic T Lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol 64:141–148
Tsutsumi S, Ohga S, Nomura A, Takada H, Sakai S, Ohshima K, Sumimoto K, Hara T (2002) CD4–CD8– T cell polymyositis in a patient with chronic active Epstein-Barr virus infection. Ame J Hematol 71:211–215
Yamamoto T, Nakamura Y, Kishimoto K, Takeuchi H, Shirakata M, Mitsuya T, Hirai K (1999) Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific unclear antigen 1. Virus Res 65:43–55
Young LS, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, Rowe DT, Greenspan D, Greenspan JS, Rickinson AB (1991) Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral “hairy” leukoplakia. J Virol 65:2868–2874
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uchiyama, T., Arai, K., Yamamoto-Tabata, T. et al. Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection. J Neurol 252, 519–525 (2005). https://doi.org/10.1007/s00415-005-0679-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0679-1